US Stock MarketDetailed Quotes

GMAB Genmab

Watchlist
  • 29.030
  • -0.690-2.32%
Close May 6 16:00 ET
  • 29.030
  • 0.0000.00%
Post 16:00 ET
18.77BMarket Cap24.23P/E (TTM)

Genmab Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
46.19%4.14B
13.57%16.47B
-8.94%4.68B
16.08%4.74B
32.76%4.2B
33.74%2.83B
72.33%14.51B
101.14%5.14B
76.93%4.09B
60.34%3.16B
Operating revenue
49.79%3.86B
14.05%15.61B
-6.31%4.6B
17.41%4.44B
32.76%4.2B
29.99%2.58B
73.56%13.69B
105.22%4.91B
74.52%3.78B
60.34%3.16B
Cost of revenue
185M
226M
126M
100M
0
0
0
0
Gross profit
39.66%3.96B
12.02%16.25B
-11.39%4.55B
13.63%4.64B
2.83B
72.33%14.51B
5.14B
4.09B
Operating expense
30.62%3.16B
32.64%10.93B
12.49%2.88B
35.76%2.93B
41.04%2.7B
50.59%2.42B
50.77%8.24B
41.55%2.56B
51.83%2.16B
61.60%1.92B
Selling and administrative expenses
26.78%857M
23.21%3.3B
1.41%934M
25.22%839M
33.97%848M
49.56%676M
108.57%2.68B
79.88%921M
118.95%670M
139.77%633M
Research and development costs
32.11%2.3B
37.18%7.63B
18.71%1.95B
40.51%2.09B
44.54%1.85B
51.00%1.74B
33.03%5.56B
26.43%1.64B
33.39%1.49B
39.20%1.28B
Operating profit
92.09%801M
-15.09%5.32B
-35.15%1.67B
-11.08%1.72B
20.05%1.5B
-18.87%417M
112.22%6.27B
246.10%2.58B
116.97%1.93B
58.45%1.25B
Net non-operating interest income expense
54.84%288M
200.99%912M
114.07%289M
158.24%235M
348.89%202M
481.25%186M
64.67%303M
321.88%135M
193.55%91M
112.33%45M
Non-operating interest income
53.65%295M
189.81%939M
110.71%295M
150.52%243M
309.80%209M
433.33%192M
64.47%324M
300.00%140M
177.14%97M
-21.54%51M
Non-operating interest expense
16.67%7M
28.57%27M
20.00%6M
33.33%8M
16.67%7M
50.00%6M
61.54%21M
66.67%5M
50.00%6M
-98.60%6M
Other net income (expense)
286.05%627M
-258.93%-596M
51.68%-1.03B
-40.00%750M
-97.99%24M
-610.61%-337M
-51.98%375M
-1,810.40%-2.14B
400.00%1.25B
1.2B
Gain on sale of security
286.05%627M
-258.93%-596M
51.68%-1.03B
-40.00%750M
-97.99%24M
-610.61%-337M
-51.98%375M
-1,810.40%-2.14B
400.00%1.25B
--1.2B
Income before tax
545.11%1.72B
-18.83%5.64B
61.89%926M
-17.42%2.7B
-30.78%1.72B
-56.54%266M
77.26%6.95B
-36.51%572M
179.42%3.27B
489.81%2.49B
Income tax
598.21%391M
-13.93%1.29B
393.10%286M
-16.96%573M
-38.80%366M
-61.90%56M
55.36%1.49B
-75.42%58M
145.55%690M
415.52%598M
Net income
530.95%1.33B
-20.18%4.35B
24.51%640M
-17.54%2.13B
-28.24%1.36B
-54.84%210M
84.38%5.45B
-22.71%514M
190.11%2.58B
517.97%1.89B
Net income continuous Operations
530.95%1.33B
-20.18%4.35B
24.51%640M
-17.54%2.13B
-28.24%1.36B
-54.84%210M
84.38%5.45B
-22.71%514M
190.11%2.58B
517.97%1.89B
Minority interest income
Net income attributable to the parent company
530.95%1.33B
-20.18%4.35B
24.51%640M
-17.54%2.13B
-28.24%1.36B
-54.84%210M
84.38%5.45B
-22.71%514M
190.11%2.58B
517.97%1.89B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
530.95%1.33B
-20.18%4.35B
24.51%640M
-17.54%2.13B
-28.24%1.36B
-54.84%210M
84.38%5.45B
-22.71%514M
190.11%2.58B
517.97%1.89B
Basic earnings per share
532.09%2.029
-20.08%6.664
24.05%0.98
-17.57%3.26
-27.95%2.08
-54.79%0.321
84.39%8.338
-22.32%0.79
190.60%3.955
516.88%2.887
Diluted earnings per share
532.60%2.018
-20.06%6.602
24.61%0.967
-17.49%3.232
-28.09%2.061
-54.75%0.319
84.48%8.259
-22.79%0.776
190.79%3.917
517.67%2.866
Dividend per share
Currency Unit
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 46.19%4.14B13.57%16.47B-8.94%4.68B16.08%4.74B32.76%4.2B33.74%2.83B72.33%14.51B101.14%5.14B76.93%4.09B60.34%3.16B
Operating revenue 49.79%3.86B14.05%15.61B-6.31%4.6B17.41%4.44B32.76%4.2B29.99%2.58B73.56%13.69B105.22%4.91B74.52%3.78B60.34%3.16B
Cost of revenue 185M226M126M100M0000
Gross profit 39.66%3.96B12.02%16.25B-11.39%4.55B13.63%4.64B2.83B72.33%14.51B5.14B4.09B
Operating expense 30.62%3.16B32.64%10.93B12.49%2.88B35.76%2.93B41.04%2.7B50.59%2.42B50.77%8.24B41.55%2.56B51.83%2.16B61.60%1.92B
Selling and administrative expenses 26.78%857M23.21%3.3B1.41%934M25.22%839M33.97%848M49.56%676M108.57%2.68B79.88%921M118.95%670M139.77%633M
Research and development costs 32.11%2.3B37.18%7.63B18.71%1.95B40.51%2.09B44.54%1.85B51.00%1.74B33.03%5.56B26.43%1.64B33.39%1.49B39.20%1.28B
Operating profit 92.09%801M-15.09%5.32B-35.15%1.67B-11.08%1.72B20.05%1.5B-18.87%417M112.22%6.27B246.10%2.58B116.97%1.93B58.45%1.25B
Net non-operating interest income expense 54.84%288M200.99%912M114.07%289M158.24%235M348.89%202M481.25%186M64.67%303M321.88%135M193.55%91M112.33%45M
Non-operating interest income 53.65%295M189.81%939M110.71%295M150.52%243M309.80%209M433.33%192M64.47%324M300.00%140M177.14%97M-21.54%51M
Non-operating interest expense 16.67%7M28.57%27M20.00%6M33.33%8M16.67%7M50.00%6M61.54%21M66.67%5M50.00%6M-98.60%6M
Other net income (expense) 286.05%627M-258.93%-596M51.68%-1.03B-40.00%750M-97.99%24M-610.61%-337M-51.98%375M-1,810.40%-2.14B400.00%1.25B1.2B
Gain on sale of security 286.05%627M-258.93%-596M51.68%-1.03B-40.00%750M-97.99%24M-610.61%-337M-51.98%375M-1,810.40%-2.14B400.00%1.25B--1.2B
Income before tax 545.11%1.72B-18.83%5.64B61.89%926M-17.42%2.7B-30.78%1.72B-56.54%266M77.26%6.95B-36.51%572M179.42%3.27B489.81%2.49B
Income tax 598.21%391M-13.93%1.29B393.10%286M-16.96%573M-38.80%366M-61.90%56M55.36%1.49B-75.42%58M145.55%690M415.52%598M
Net income 530.95%1.33B-20.18%4.35B24.51%640M-17.54%2.13B-28.24%1.36B-54.84%210M84.38%5.45B-22.71%514M190.11%2.58B517.97%1.89B
Net income continuous Operations 530.95%1.33B-20.18%4.35B24.51%640M-17.54%2.13B-28.24%1.36B-54.84%210M84.38%5.45B-22.71%514M190.11%2.58B517.97%1.89B
Minority interest income
Net income attributable to the parent company 530.95%1.33B-20.18%4.35B24.51%640M-17.54%2.13B-28.24%1.36B-54.84%210M84.38%5.45B-22.71%514M190.11%2.58B517.97%1.89B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 530.95%1.33B-20.18%4.35B24.51%640M-17.54%2.13B-28.24%1.36B-54.84%210M84.38%5.45B-22.71%514M190.11%2.58B517.97%1.89B
Basic earnings per share 532.09%2.029-20.08%6.66424.05%0.98-17.57%3.26-27.95%2.08-54.79%0.32184.39%8.338-22.32%0.79190.60%3.955516.88%2.887
Diluted earnings per share 532.60%2.018-20.06%6.60224.61%0.967-17.49%3.232-28.09%2.061-54.75%0.31984.48%8.259-22.79%0.776190.79%3.917517.67%2.866
Dividend per share
Currency Unit DKKDKKDKKDKKDKKDKKDKKDKKDKKDKK
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg